Alchemab Therapeutics has secured £25m/$34m from the British Business Bank – the Bank’s largest investment in a life sciences ...

Agreement with leading life sciences company Illumina strengthens Bifrost’s path to commercial deployment of next-generation optical pooled screening technology.BERKELEY, Calif.--(BUSINESS ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

Aardaia will use the new funding to expand its crop breeding platform and accelerate the development of the aardaker, a ...

The Centre for Nano Science and Engineering (CeNSE) at IISc Bengaluru is bringing researchers, entrepreneurs and advanced ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, ...

Julie Coletti "is a highly accomplished legal and business leader with deep experience across the life sciences and medical ...

But that narrative is starting to look stale, and the theme appears extended after the SOXX ETF more than doubled between ...

Illumina stock has surged over the past year, and the current debate centers on a split valuation picture, with a Discounted ...

Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable critical minerals recovery and lithium battery recycling, today ...

Active Motif inks global distribution agreement with Arima Genomics for advanced 3D genomics solutions: Carlsbad, California Wednesday, July 8, 2026, 17:00 Hrs [IST] Active Motif, ...

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...